NTX-1107

N/A

Report date: 2024/03/21 14:23:24

Base Information

Drug NameNTX-1107
Drug Alias NameNTX1107
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionNectin-2 inhibitors
TargetsNectin-2
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNectin Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNectin Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A